High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery
Matteo Martufi, Eleni Karagianni, Tasos Papanikos, Tim G. Ashlin, Aikaterini Geladaki, Benedetta Carbone, Katja S. Remlinger, Andres Quintero Moreno, William G. Pembroke, Charlie Haslam, Nico Zinn, Denise F. Vlachou, Margarida Almeida, Dimitrios Tsaousis, Stephan Gade, , Lisa Mohamet
The paper establishes a CRISPR/Cas9 screening platform in hiPSC-derived macrophages to identify genetic targets influencing inflammatory responses and functional phenotypes.
bioRxiv · Sep 14, 2026 · PreprintImmunology